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risk factors of hepatic aGVHD (Figure 2) and that hepatic
dysfunction due to HCV infection conferred an especially
higher risk (HR, 6.87; p < 0.01). These factors were speciﬁc
for hepatic aGVHD, and not signiﬁcant for skin or gut aGVHD.
HBs antigens (HR, 0.64; p ¼ 0.13) and massive erythrocyte
transfusions (HR, 1.08; p ¼ 0.44) were not signiﬁcant,
whereas SCT at progressive disease, Rel-PB or UR-BM, HLA
mismatch, and use of cyclosporine A as aGVHD prophylaxis
were signiﬁcant risk factors of hepatic aGVHD.
Discussion and Conclusion: This study suggests that
chronic inﬂammation and injury of liver before SCT can
induce aGVHD. Modiﬁcation of aGVHD prophylaxis and early
intervention may improve the prognosis of patients with
high-risk factors such as those indicated in this study.471
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Introduction: Patients undergoing hematopoietic stem cell
transplantation may experience a range of neurological
complications; moreover, etiologies for neurological com-
plications may be difﬁcult to differentiate but may occur
from the conditioning regimen, the interval of pancytopenia
lending to infection and bleeding, prophylactic drugs, or
from recurrence. Here we present a complex case of chronic
GVHD involving the Central Nervous System (CNS cGVHD).
Case Report: A 16-year old African American male under-
went mismatched unrelated allogeneic double UCBT for
biphenotypic leukemia. At day +25, the patient developed
rash to his palms and soles along with abdominal cramping,
voluminous diarrhea, nausea, vomiting, and fever. Biopsies of
the upper and lower GI tract were consistent with acute
GVHD. He was treated accordingly. Diarrhea only improved
with diet restriction.
His clinical coursewas further complicated by progressive
neurologic issues (anomic aphasia, confusion, agitation and
hallucinations). A new ill-deﬁned T2/FLAIR signal abnor-
mality was seen in the bilateral cerebral hemispheric white
matter (serum/CSF negative for infection or relapse). Brain
biopsy was considered but not performed during patient’s
course of altered mental status. Unfortunately he succumbed
to complications, the etiology of which was debated ad-
nauseam.
Examination of brain at autopsy revealed immune
mediated encephalitis, vasculitis, and CNS demyelination. A
diagnosis of “possible chronic CVHD of the CNS” was
rendered at the patient’s M&M.
Discussion: Neurological complications (regimen-related
toxicities, infections, cerebrovascular events and metabolic
disorders) pose a signiﬁcant source for morbidity and mor-
tality following allogeneic HSCT with the incidence varying
between 10 to 55% in reported studies. This case’s autopsyﬁndings revealed immune mediated encephalitis, multifocal
CNS demyelination, and vascular changes.
The neurological manifestations of CNS cGVHD are rare
and can affect both the peripheral and central nervous sys-
tem. However, CNS chronic GVHD remains controversial.
There have been at least 18 reported cases of presumed CNS
cGVHD since 1990 of which ﬁndings included demyelinating
disease, angiitis, vasculitis and immune-mediated encepha-
litis. The diagnostic criteria for chronic GVHD of the CNS
requires that all six of the following criteria for a deﬁnitive
diagnosis of CNS GVHD: (1) a-priori chronic GVHD affecting
other organs, (2) Neurological signs of CNS involvement, (3)
MRI abnormality, (4) Abnormal CSF studies, (5) Pathological
brain biopsy or post-mortem examination, and (6) Response
to therapy.
While the criteria allows for a very speciﬁc diagnosis of
CNS cGVHD, the criteria are too stringent. Herein, a modiﬁed
criteria stratiﬁed by pathologic examination of involved
neural tissue is proposed.472
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Background: Haplotype mismatches have been associated
with higher risk of GVHD in patients receiving 8/8 HLA
matched HCT. In addition a CIBMTR genomewide association
study identiﬁed SNP mismatches within the MHC region in
association with higher risk of GVHD. However, current
standard of care relies only onmatching at class I (A, B, C) and
class II (DRB1) loci. The gamma block (GB) is located in the
central MHC region between the genomic blocks that include
HLA-C/B and DRB1/DQB1 and is the only major genomic
block within the MHC not currently considered in HCT donor
selection. We tested the hypothesis that mismatches in the
GB increase the risk of GVHD.
Methods: We investigated 25 GB SNPs in 236 HCT recipient/
unrelated donor pairs transplanted at our center (2000-
2010). High resolution typing of HLA A, B, C, DRB1, DQB1,
DPB1 loci and for MHC class I related chain A (MICA) was
performed by sequence speciﬁc oligonucleotide probes and/
or sequencing. GB SNP typing was performed by sequence
speciﬁc primers. SNPs associated with severe acute GHVD
(grades III-IV) at P<0.20 were combined into a composite
variable. Multivariate analysis using Fine and Gray regression
was used to identify risk factors for severe acute GVHD with
adjustment for other signiﬁcant risk factors.
Results: The study included AML (n¼89), ALL (41), MDS (34),
NHL (28) and other diagnoses (44). Stem cell source was BM
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intermediate and advanced in 98, 69 and 69 recipients,
respectively. Conditioning intensity was myeloablative (vs.
reduced intensity) in 176 (75%) recipients. GVHD prophylaxis
was MTX based, MMF based and FK in 152, 74 and 10 re-
cipients, respectively. HLA match was 8/8 and 10/10 in 184
(78%) and 179 (76%) pairs, respectively. HLA-DPB1 and MICA
were matched in 44 (19%) and 197 (85%) recipients, respec-
tively. Recipients included 137 (58%) males, 222 (94%) white.
Mean age was 4414 years.
SNPs c.2918+98G, c.3316C, and c.4385C (reference
sequence C4A NG_011638.1) were associated with severe
GVHD and analyzed as a composite variable. Mismatch at 1
of the 3 SNPs occurred in 49 pairs and 187 were matched
across all 3 SNPs. SNP mismatch was associated with
increased risk of severe GVHD in univariable analysis (HR
2.43, 95% CI 1.32-4.47, P¼0.004). There were no signiﬁcant
differences among SNP match and mismatch pairs regarding
HLA match (10/10 vs. <10/10, 8/8 vs. <8/8, DPB1), MICA
match, and patient, disease or transplant characteristics. SNP
mismatch remained signiﬁcantly associated with severe
GVHD in a multivariable analysis (HR 2.54, P¼0.002) after
adjusting for graft source, HLA and MICA mismatch.
Conclusion: GB SNPmismatch is associatedwith a higher risk
of severe acute GVHD independent of the HLA and MICA
match and other clinical risk factors. Avoiding GB SNP
mismatch can potentially reduce the risk of severe acute
GVHD and further investigation in larger cohorts is warranted.473
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Introduction: Killer-cell immunoglobulin-like receptors
(KIRs) are highly polymorphic. Donor KIR2DL1-R 245 poly-
morphism has been associated with stronger signaling
function than others. Our aim is to evaluate this donor
polymorphism in the setting of T cell-repleted haploidentical
hematopoietic stem-cell transplantation (HSCT) with post-
infusion high-dose cyclophosphamide (PiCy).
Patients and Methods: Thirty-nine adult patients who un-
derwent T-cell repleted haploidentical HSCT with PiCy in a
single center were included. Median age was 41 (r: 19-65).
Diagnosis was: Hodgkin’s Lymphoma 11 (28%), Acute
Myeloid Leukemia 14 (35%), Myelodisplastic Syndrome 3
(8%), Acute Lymphoblastic Leukemia 4 (11%), Myeloprolifer-
ative Syndromes 1 (2%), Non-Hodking Lymphoma 4 (11%),
Multiple Myeloma 2 (5%). Conditioning regimen was: mye-
loablative in 16 patients and reduced intensity in 23 patients.
The donor-patient kinshipwas: father in 5 cases (5%), mother
in 10 cases (26%), sibling in 17 cases (44%) and son/daughter
in 7 cases (18%). Donor KIR2DL1 functional allele typing was
retrospectively performed using single nucleotide poly-
morphism assay (Bari et al, Clinical Immunology 2011). KIR
genotype was analyzed by PCR (KIR Typing, Miltenyi Biotec)
using genomic DNA puriﬁed by the (Maxwell 16 Blood DNA
Kit, Promega) from peripheral blood examples. KIR ampli-
cons were visualized with ethidium bromide after agarose
gel electrophoresis. HLA typing was used to identify HLAclass I KIR ligands: HLA-C alleles with a Lys80 residue (C2
alleles), HLA-C with an Asn80 residue (C1 alleles), and HLA-B
alleles with Bw4 and Bw6 speciﬁcity.
Results: Donor KIR2DL1 polymorphismwas: KIR2DL1-R 245
homozygous 26 (66.6%), KIR2DL1-R 245/C245 13 (33,3%),
KIR2DL1-C 245 homozygous 0 (0%). Donor KIR haplotipe was
A-A in 4 (12%) and Bx in 34 (87%). Patient haplotype was A-A
in 7 (18%) and Bx in 32 (82%). Thirteen patients received a
KIR2DL1-R 245 homozygous graft with HLA-C ligand-re-
ceptor mismatch, 13 patients received a KIR2DL1-R 245 graft
with no HLA-C ligand-receptor mismatch and 12 patients
received a KIR2DL1-R 245/KIR2DL1-C245 graft. We did not
ﬁnd event free survival (EFS) differences between patients
who received a KIR2DL1-R 245 homozygous graft or a
KIR2DL1-R 245/KIR2DL1-C245 graft (67% vs 68% p¼0.37).
However, patients who received a KIR2DL1-R 245 graft with
HLA-C ligand-receptor mismatch had a marked tendency to
better event free survival (EFS) compared with those who
received a graft with KIR2DL1-R 245 and no HLA-C ligand-
receptor mismatch (80% vs 100% respectively, p¼0.057) one
year after transplant
Conclusion: Donor KIR2DL1-R 245 allelic polymorphism
associated with KIR HLA-C ligand-receptor mismatch could
affect recipient outcomes after T cell-repleted haploidentical
HSCT with PiCy. These ﬁndings could have signiﬁcant
repercussion for donor selection.474
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Chronic graft-versus-host disease (cGVHD) is a major cause
of morbidity and mortality following allogeneic hemato-
poietic stem cell transplant (AHSCT). Although current
therapies largely target T cell proliferation, in vivo T cell
kinetics of division, death and trafﬁcking have been difﬁ-
cult to evaluate. We employed deuterated water labeling
with subsequent GC-MS/MS enrichment detection to
measure in vivo T cell kinetics after AHSCT in a mouse
model of cGVHD. We investigated CD4 T cell sub-popula-
tion kinetics of cell division, death and trafﬁcking, in non-
target and target tissues of cGVHD. Early in the disease
course, spleens of AHSCT recipients showed a high number
of CD4+ T regulatory (Treg) and T effector memory (Tem)
cells. In vivo cell division kinetics of these two cell types
were high and similar to each other, and slowed as cGVHD
progressed. Meanwhile, Tem cell loss from the spleen was
signiﬁcantly faster than that of Treg cells, likely as a result
of increased trafﬁcking. In support of trafﬁcking was the
ﬁnding of elevated Tem numbers in peripheral blood of
AHSCT recipients despite a relative lymphopenia early in
the disease with subsequent disappearance from the cir-
culation once cGVHD was clinically evident. Furthermore,
overall Tem cell numbers in the host were signiﬁcantly
